The present study sought to explore the predictive value of radial wall strain (RWS, derived solely from angiograms) for coronary artery lesion progression compared with lesion vulnerability assessed by optical coherence tomography (OCT). The lesion progression at 1 year was defined as an increase of ≥20% in diameter stenosis based on quantitative coronary angiography (QCA) evaluation.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* General Inclusion Criteria:
1. Age ≥18 years
2. Acute myocardial infarction ≤ 45 days
3. Planned coronary angiography examination or potential interventional treatment
* Angiographic Inclusion Criteria:
1. The presence of at least 1 non-flow-restricting lesion (visually estimated diameter stenosis: 30%-80%; QFR \> 0.80) in any non-infarct related artery with RVD ≥2.5 mm by visual assessment
Exclusion Criteria:
* General exclusion Criteria:
1. Cardiogenic shock
2. Pregnant or woman of child-bearing potential
3. Life expectancy less than 1 year for non-cardiac causes
4. Unable to tolerate contrast agents or anticoagulant/antiplatelet therapy
5. Prior CABG or planned CABG
* Angiographic exclusion Criteria:
1. Poor angiographic image quality precluding vessel contour detection or with suboptimal contrast opacification, branch ostium cannot be shown clearly, severe overlap in the stenosed segment or severe tortuosity of any interrogated vessel deemed not amenable to QFR or RWS measurement
2. An interrogated lesion require surgical bypass grafting
3. Unable to judge culprit lesion or infarct-related artery according to current evidence
Primary outcome measure(s)
Lesion progression assessed by QCA — 1 year Defined as an increase of ≥20% in diameter stenosis based on QCA evaluation
Trial sites (1)
Facility
City
Region
Status
Lei Song
Beijing
China
Recruiting
More China National Center for Cardiovascular Diseases trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.